Hepatitis C Virus
New data from the United States, South Korea and United Kingdom lluminates research in hepatitis C virus
Published in Hepatitis Weekly, July 3rd, 2006
Study 1: According to a study from the United States, hepatitis C virus (HCV) protease inhibitors prevent interferon (IFN)-beta promoter stimulator-1 (IPS-1) proteolysis.
"Viral signaling through retinoic acid-inducible gene-I (RIG-I) and its adaptor protein, IPS-1, activates IFN regulatory factor-3 (IRF-3) and the host IFN-alpha/beta response that limits virus infection. HCV NS3/4A protease cleaves IPS-1 to block RIG-I signaling, but how this regulation controls the host response to HCV is not known," wrote Y.M. Loo and colleagues, University of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-07-03)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Transfected hepatitis B virus genes are expressed in early embryonic cells - Hepatitis C Genetics
Epigenetic silencing influences interferon resistance of HCV replicon-harboring cells - Hepatitis C Virus
HCV hepatoma cell entry is inhibited by oxidized low-density lipoprotein - Hepatitis C Virus
HCV NS5A protein is cleaved to produce truncated and mainly cytosolic forms - Hepatitis C Virus
HCV-reactive T cell receptor does not require CD8 for target cell recognition - Allergy & Immunology
Dynavax announces completion of enrollment in Tolamba ragweed allergy trial - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
